Huey-Kang Sytwu

InstitutionNational Health Research Institutes
AddressMiaoli
Taiwan
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 9 Covid-19 publications, with a maximum of 3 publications in May 2020
    All Publications
    Bar chart showing 150 publications over 20 distinct years, with a maximum of 16 publications in 2013
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Wang LT, Liu KJ, Sytwu HK, Yen ML, Yen BL. Advances in mesenchymal stem cell therapy for immune and inflammatory diseases: Use of cell-free products and human pluripotent stem cell-derived mesenchymal stem cells. Stem Cells Transl Med. 2021 09; 10(9):1288-1303. PMID: 34008922.
      Citations: 7     Fields:    Translation:HumansCells
    2. Yang CW, Lee YZ, Hsu HY, Jan JT, Lin YL, Chang SY, Peng TT, Yang RB, Liang JJ, Liao CC, Chao TL, Pang YH, Kao HC, Huang WZ, Lin JH, Chang CP, Niu GH, Wu SH, Sytwu HK, Chen CT, Lee SJ. Inhibition of SARS-CoV-2 by Highly Potent Broad-Spectrum Anti-Coronaviral Tylophorine-Based Derivatives. Front Pharmacol. 2020; 11:606097. PMID: 33519469.
      Citations: 6     
    3. Sytwu HK. Expeditious responses to COVID-19 crisis: From governmental management to laboratory approach. Biomed J. 2020 08; 43(4):311-313. PMID: 33046218.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    4. Tsou HH, Cheng YC, Yuan HY, Hsu YT, Wu HY, Lee FJ, Hsiung CA, Chen WJ, Sytwu HK, Wu SI, Shih SM, Wen TH, Kuo SC. The effect of preventing subclinical transmission on the containment of COVID-19: Mathematical modeling and experience in Taiwan. Contemp Clin Trials. 2020 09; 96:106101. PMID: 32771432.
      Citations: 3     Fields:    Translation:HumansCellsPHPublic Health
    5. Yen BL, Yen ML, Wang LT, Liu KJ, Sytwu HK. Current status of mesenchymal stem cell therapy for immune/inflammatory lung disorders: Gleaning insights for possible use in COVID-19. Stem Cells Transl Med. 2020 10; 9(10):1163-1173. PMID: 32526079.
      Citations: 20     Fields:    Translation:HumansCellsPHPublic Health
    6. Chang FY, Chen HC, Chen PJ, Ho MS, Hsieh SL, Lin JC, Liu FT, Sytwu HK. Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19). J Biomed Sci. 2020 Jun 04; 27(1):72. PMID: 32498686.
      Citations: 16     Fields:    Translation:HumansCellsPHPublic Health
    7. Huang SF, Huang YC, Chang FY, Lin JC, Chiu CH, Chen CW, Wang FD, Chiu YL, Cheng SH, Cheng CY, Lin YC, Chen CP, Huang CH, Liu PY, Lee YT, Lee CH, Chen YS, Sy CL, Tseng YT, Hsu CT, Tseng CC, Lee YL, Liu CE, Sytwu HK. Rapid establishment of a COVID-19 biobank in NHRI by National Biobank Consortium of Taiwan. Biomed J. 2020 08; 43(4):314-317. PMID: 32563697.
      Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
    8. Yang CW, Peng TT, Hsu HY, Lee YZ, Wu SH, Lin WH, Ke YY, Hsu TA, Yeh TK, Huang WZ, Lin JH, Sytwu HK, Chen CT, Lee SJ. Repurposing old drugs as antiviral agents for coronaviruses. Biomed J. 2020 08; 43(4):368-374. PMID: 32563698.
      Citations: 19     Fields:    Translation:HumansCellsPHPublic Health
    9. Ke YY, Peng TT, Yeh TK, Huang WZ, Chang SE, Wu SH, Hung HC, Hsu TA, Lee SJ, Song JS, Lin WH, Chiang TJ, Lin JH, Sytwu HK, Chen CT. Artificial intelligence approach fighting COVID-19 with repurposing drugs. Biomed J. 2020 08; 43(4):355-362. PMID: 32426387.
      Citations: 57     Fields:    Translation:HumansCellsPHPublic Health